Canada's CCAB likes India for manufacturing its antibody products; Alveda buys IGI Laboratories;

> After partnering with India's Zydus Cadila for its first antibody-based cancer treatments, Canada's Centre for Commercialisation of Antibodies and Biologics (CCAB) says it is impressed by India's manufacturing capabilities and will look for partnerships there for some of its other 1,000 antibodies. Report

> Canada's Alveda Pharmaceuticals, which uses European CMOS to produce its generic injectable drugs, will be acquired by New Jersey based IGI Laboratories, for $47 million. Report

> Mankind Pharma says it has invested Rs 150 crore ($23 million) in its plant at Paonta Sahib and expects to add 35 nutraceutical, food supplement and beverage products by the end of next year. Report

And Finally... Former NBA star Lamar Odom was found unconscious in a Nevada brothel, whose owner said Odom had taken large amounts of an herbal Viagra that the FDA had warned consumers about. Story